Wellcome Trust - Medical Research Council Stem Cell Institute and Department of Biochemistry, Tennis Court Road, University of Cambridge, Cambridge CB2 1QR, UK.
Biochem Soc Trans. 2013 Jun;41(3):777-82. doi: 10.1042/BST20130027.
The CHD4 (chromodomain-helicase-DNA-binding 4) (or Mi-2β) protein is a founding component of the NuRD (nucleosome remodelling and deacetylation) complex. NuRD has long been known to function in transcriptional regulation, and is conserved throughout the animal and plant kingdoms. In recent years, evidence has steadily accumulated indicating that CHD4 can both function outside of the NuRD complex and also play important roles in cellular processes other than transcriptional regulation. A number of loss-of-function studies have identified important roles for CHD4 in the DNA-damage response and in cell cycle progression through S-phase and into G2. Furthermore, as part of NuRD, it participates in regulating acetylation levels of p53, thereby indirectly regulating the G1/S cell cycle checkpoint. Although CHD4 has a somewhat complicated relationship with the cell cycle, recent evidence indicates that CHD4 may exert some tumour-suppressor functions in human carcinogenesis. CHD4 is a defining member of the NuRD complex, but evidence is accumulating that CHD4 also plays important NuRD-independent roles in the DNA-damage response and cell cycle progression, as well as in transcriptional regulation.
CHD4(染色质解旋酶-DNA 结合蛋白 4)(或 Mi-2β)蛋白是 NuRD(核小体重塑和去乙酰化)复合物的基本组成部分。NuRD 长期以来一直被认为在转录调控中发挥作用,并在动物和植物王国中都得到了保守。近年来,越来越多的证据表明,CHD4 不仅可以在 NuRD 复合物之外发挥作用,而且在转录调控以外的细胞过程中也发挥着重要作用。一些丧失功能的研究表明,CHD4 在 DNA 损伤反应以及通过 S 期进入 G2 期的细胞周期进程中发挥重要作用。此外,作为 NuRD 的一部分,它参与调节 p53 的乙酰化水平,从而间接调节 G1/S 细胞周期检查点。尽管 CHD4 与细胞周期的关系有些复杂,但最近的证据表明,CHD4 在人类肿瘤发生中可能发挥一些肿瘤抑制功能。CHD4 是 NuRD 复合物的定义成员,但越来越多的证据表明,CHD4 在 DNA 损伤反应和细胞周期进程以及转录调控中也发挥着重要的非 NuRD 依赖性作用。